Get Permission Prakhya, Mythili D, Reddy, and Agrawal: A rare case report of a malignancy of prostate


Case Report

A 70 year old male presented to the out patient department at a hospital with complaints of loss of weight and difficulty in micturition. A related routine exam revealed a hard mass in the transitional zone of the prostate. No other significant history was noted. TURP was performed and the specimen was subjected to histological examination. The anatomic pathology department of our laboratory received multiple chips of the prostate aggregating to 20 grams all of which was processed for microscopy. Microscopic examination of the tissue revealed a highly malignant tumor with the composition of spindle cells with severe pleomorphism encircling prostatic glands with carcinomatous transformation. A diagnosis of a carcinosarcoma was arrived at with positivity of PanCK, PSA immunohistochemical markers (with DAKO antibodies/anti mouse and rabbit monoclones) as shown in images.1, 2, 3, 4, 5, 6

Discussion and Review of Literature

The case presented here reveals the straight forward clinical diagnostic importance. Per rectal examination findings combined with biopsies have 100% success rate in these malignancies as per our review of the literature. In this case, a differential diagnosis of leiomyosarcoma was also considered owing to the cellular morphology but was ruled out with immunohistochemical markers. The etiology is unknown and there were no osseous components of metaplasia usually seen in such cases. The causative factor in this case warrants further investigation.

Regarding the carcinogenesis of prostatic carcinosarcoma there were the following proposed; 1) incidental occurence 2) de-differentiation of immature stem cells 3) transformation from adenocarcinoma into sarcoma 4) transformation from sarcoma into adenocarcinoma 5) tumor differentiation due to radiotherapy and hormonal therapy effects.

Hansel and Epstein have performed several works in relation to this malignancy. Hansel and Epstein examined specimens of the prostate gland which were obtained by means of trans-urethral resection, needle biopsy of prostate and radical prostatectomy from 42 patients who had been diagnosed as having sarcomatoid carcinoma of the prostate gland.6 PSA levels are usually within normal range in sarcomas of prostate. A possible explanation for this lack of elevated PSA is that the tumor cells have "dedifferentiated" to a cell type that expresses a much smaller, and perhaps abnormal, prostatic specific antigen. Similar results have been reported for serum prostatic acid phosphatase. Dedifferentiated and undifferentiated cancer cells especialy in cases such as these and have no capacity to raise serum PSA levels. Therefore, only a small number of patients have an elevated serum PSA level.5

Figure 1

40x Hematoxylin & Eosin – carcinosarcomatous element of biopsy

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/d3ac2525-e568-4fa9-b32d-3e7a85194247/image/673fddfe-1d59-4a2c-9906-6e0d5e8d9ee7-uimage.png

Figure 2

40x Hematoxylin & Eosin – carcinosarcomatous element of biopsy

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/d3ac2525-e568-4fa9-b32d-3e7a85194247/image/777e898e-220e-444c-8286-91397da3c5f2-uimage.png

Figure 3

40x Immunohistochemistry – PanCK positivity

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/d3ac2525-e568-4fa9-b32d-3e7a85194247/image/92ca7d3a-496f-48a6-80b4-952e94601f05-uimage.png

Figure 4

40x Immunohistochemistry – PSA negative

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/d3ac2525-e568-4fa9-b32d-3e7a85194247/image/085c2c41-be65-4f2b-97aa-f57083759994-uimage.png

When the sarcomatoid carcinoma diagnosed, in about 25% of cases have metastasis. The most frequent site of metastasis was the lung. As per Weiss and Enzinger et al.2 radiation therapy, antiandrogen therapy, histologic subtype, necrosis rate, grade of sarcoma are not predictive to estimate overall survival. Only negative surgical margins and the absence of metastasis have a positive effect on survival. If the carcinosarcoma spreads to the whole prostate tissue survival is reported to be about six months.3

A plausible overiew of the literature is underplaying the role of the carcinosarcoma of the prostate gland when it comes to its rarity. The prevalence of case reports appears to be gradually increasing with time, though whether this phenomenon is due to the increased utilization of therapeutic protocols hypothesized to play a causative role in the development of carcinosarcomas3 or, instead, merely to an increased recognition and reporting of this rare diagnostic entity, is unclear from the scope of this review. Notwithstanding, from our review and evaluation of the literature, we found that all carcinosarcomas of the prostate, once diagnosed, regardless of their etiology - spontaneous, after conventional therapy or after radiation therapy-appear to behave in a similar manner, with frequent metastasis and poor outcome and c-myc oncogene elaboration.

As per our conclusion, this type of malignancy is highly rare post review of the literature. They also seem to highly agressive, spreading and aggressive with not enough case numbers to define a course of standard management. TURP and needle biopsy diagnoses combiend with PSA testing are golf standard. Large-scale researches in the future will be better to recognize the carcinosarcoma and shed light on the most appropriate treatment method. Better research and genetic studies are warranted to reduce the incidence of such deadly morbid tumors.

Source of Funding

None.

Conflict of Interest

None.

References

1 

Steven C. Quay Karl H. Proppe Carcinosarcoma of the Prostate: Case Report and Review of the LiteratureJ Urol1981125343680022-5347, 1527-3792Ovid Technologies (Wolters Kluwer Health)

2 

J A Somarelli M K Boss J I Epstein Carcinosarcomas: tumors in transition?Histol Histopathol20153067387

3 

CRAIG G. Rogers A Parwani A Tekes Mark P. Schoenberg Jonathan I. Epstein Carcinosarcoma of the prostate with urothelial and squamous componentsJ Urol20051732439400022-5347, 1527-3792Ovid Technologies (Wolters Kluwer Health)

4 

Giulia Orsatti Francis J. Corgan Steven A. Goldberg Carcinosarcoma of urothelial organs: Sequential involvement of urinary bladder, ureter, and renal pelvisUrol1993413289910090-4295Elsevier BV

5 

Donna E. Hansel Jonathan I. Epstein Sarcomatoid Carcinoma of the Prostate: A Study of 42 CasesAm J Surg Pathol200630101316210147-5185Ovid Technologies (Wolters Kluwer Health)

6 

Donna E Hansel Mehsati Herawi Elizabeth Montgomery Jonathan I Epstein Spindle cell lesions of the adult prostateMod Pathol2007201148580893-3952, 1530-0285Springer Science and Business Media LLC



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2020.100


Article Metrics






Article Access statistics

Viewed: 1101

PDF Downloaded: 582